Print Page  Close Window


SEC Filings

8-K
OREXIGEN THERAPEUTICS, INC. filed this Form 8-K on 12/14/2018
Entire Document
 


In re: Orexigen Therapeutics, Inc.

Debtor

  

Case No. 18-10518 (KG)

Reporting Period: November 1, 2018 - November 30, 2018

 

MOR-5

Accounts Receivable Aging

As of November 30, 2018

(Unaudited)

 

$ USD ‘000s                                    

Accounts Receivable Aging

      Current             0-30 Days             31-60 Days             61-90 Days             91 Days +             Total      

Accounts Receivable, net

  $ —       $ —       $ —       $ —       $ —       $ —    
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  $ —       $ —       $ —       $ —       $ —       $ —  

Debtor Questionnaire

 

Must be completed each month

  

      Yes      

  

      No      

1.   Have any assets been sold or transferred outside the normal course of business this reporting period? If yes, provide an explanation below.       X
2.   Have any funds been disbursed from any account other than a debtor in possession account this reporting period? If yes, provide an explanation below.       X
3.   Have all post petition tax returns been timely filed? If no, provide an explanation below.    X   
4.   Are workers compensation, general liability and other necessary insurance coverages in effect? If no, provide an explanation below.    X   
5.   Has any bank account been opened during the reporting period? If yes, provide documentation identifying the opened account(s). If an investment account has been opened provide the required documentation pursuant to the Delaware Local Rule 4001-3.       X